Mode
Text Size
Log in / Sign up
N/A N=8 Supportive Care

Safety and Feasibility of tDCS to Enhance Auditory Rehabilitation in Cochlear Implant Recipients

Hearing Loss

Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Number Eligible Patients Who Expressed Interest in the Study — 61 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Transcranial Direct Stimulation (Device); Auditory Training Program (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Jul 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number Eligible Patients Who Expressed Interest in the Study
61
PRIMARY
Number of Subjects Who Completed tDCS Training
6
PRIMARY
Number of Participants Who Demonstrated Competence of tDCS Training
7
PRIMARY
Number of Participants Who Reported Ease of Completing the Training Program
6
PRIMARY
Number of Participants Who Reported an Adverse Event
PRIMARY
Number of Participants Who Experienced Skin Irritation From Use of tDCS
6
PRIMARY
Number of Subjects Who Experienced Abnormal Function of Cochlear Implant Device
PRIMARY
Speech Perception Performance - Sentence Recognition in Quiet
59.6; 68.8; 67.4
PRIMARY
Speech Perception Performance - Word Recognition Performance
43.1; 55.3; 47.2
PRIMARY
Communication Function as Measured by Speech, Spatial and Qualities of Hearing (SSQ12) Questionnaire
3.6; 4.5; 4.5
PRIMARY
Cochlear Implant Quality of Life-35 Profile (CIQOL35) Questionnaire
32.9; 36.0; 36.8
SECONDARY
Number of Participants Who Enjoyed Doing the Listening Exercises on the Computer
6
SECONDARY
Number of Participants Who Reported Use of the Stimulation Device to be Acceptable
4
SECONDARY
Number of Participants Who Reported Improvement in Hearing Performance
5
SECONDARY
Number of Participants Who Would Recommend the Training Program
4
SECONDARY
Number of Participants Who Reported Acceptable Compensation for Study Participation
6

Summary

This study aims to evaluate the safety and feasibility of transcranial direct current stimulation (tDCS) in combination with home-based auditory training therapy in cochlear implant (CI) patients. Changes in speech perception performance will also be evaluated.

Eligibility Criteria

Inclusion Criteria

  • Age >/= 18 years of age
  • Patients with a Unilateral Cochlear Implant device in use for a minimum of 1 year
  • Sentence recognition scores (AzBio) below 65% and/or word recognition scores (CNC) are below 75% in the implanted ear for > one year following cochlear implantation.
  • Ability to access internet to conduct computer-based auditory trainings and weekly video visits with study team weeks 2-5

Exclusion Criteria

  • Non-English speaking
  • Diagnosis (documented or self-reported) of a psychiatric or neurologic condition, or any other comorbidities that may interfere with the study or increase the level of risk (such as dementia, seizures, legal blindness, brain tumor)
  • Implants, other than CI, above collar bone level that may interact with delivery of tDCS
  • Inability to or unwillingness to use electronic devices/computers, participate in video visits, or make required visits
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04908631). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search